Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.
about
Last generation triazoles for imported eumycetoma in eleven consecutive adultsPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain.Voriconazole-induced periostitis.Risk Assessment of Fluoride Intake from Tea in the Republic of Ireland and its Implications for Public Health and Water Fluoridation.Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell TransplantationVoriconazole-Induced Periostitis & Enthesopathy in Solid Organ Transplant Patients: Case Reports.Voriconazole-induced periostitis in a patient with overlap syndromesMultifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long-term voriconazole.Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.Voriconazole-induced periostitis post transplant: an illustrative review of thoracic computed tomography imaging manifestations.Voriconazole-induced periostitis: beyond post-transplant patients.An update on drug-induced arthritis.Voriconazole-induced periostitis: a new rheumatic disorder.The anti-Aspergillus drug pipeline: Is the glass half full or empty?An update on the safety and interactions of antifungal drugs in stem cell transplant recipients.Updated practice guidelines for the diagnosis and management of aspergillosis: challenges and opportunities.Voriconazole Enhances the Osteogenic Activity of Human Osteoblasts In Vitro through a Fluoride-Independent MechanismVoriconazole-induced periostitis after allogeneic stem cell transplantation.Voriconazole-Induced Periostitis Deformans: A Mimicker of Hypertrophic Pulmonary Osteoarthropathy.Fluorosis and periostitis deformans as complications of prolonged voriconazole treatment.Painful periostitis in the setting of chronic voriconazole therapy.Voriconazole-related periostitis presenting on magnetic resonance imaging.Arterial calcification due to CD73 deficiency (ACDC): imaging manifestations of ectopic mineralization.Voriconazole-induced periostitis deformans: serial imaging in a patient with ANCA vasculitis.Voriconazole-associated soft tissue ossification: an undescribed cause of glenohumeral joint capsulitis.Diffuse periostitis as the primary presenting radiological finding in an AML patient with disease relapse
P2860
Q34315079-466DA92C-6333-49D9-AEBA-33C0A80411B8Q34532546-7EBBE7DE-2DFA-41F3-9EFF-DC8D28F8ADDFQ35152691-E0ACB6B7-32F6-4CCA-8090-0C9F06889587Q36117304-CD3887E8-0C65-43FD-8DED-3B3307FC5CE5Q36732262-F07DA8A7-44FA-4C69-8B0E-1316DD500E3CQ37043809-A317A45F-B67B-4584-BD37-F6BEF868F48FQ37505993-E8B2D059-DA95-435E-887B-3D38DDB21621Q37627809-21605ADE-8D8F-4798-BCEA-8C4AE4894861Q38105648-54B3AC99-4C49-416D-A830-4534F3F6585FQ38261282-C2D6D3D4-8D0D-47DB-A32D-7744B2CEB79BQ38284468-C5B1D872-FFAD-410E-89A5-FD7592142C25Q38582397-17993484-63E9-48FB-8332-178747BD8880Q38775993-9E0F20DB-56AE-42AA-963A-4A3A75FD61C2Q38783509-2931EF1B-8586-4BF4-BE9A-A6969778370BQ38885518-5D2EAEA7-FA01-4308-A388-0173906F7B80Q38937577-F601AB70-9B13-4250-8696-F6AA0BB8C538Q39048531-9627BFC4-B615-4F62-98A7-B97EBBD223BDQ40349447-69FD3894-1F2D-4C30-9ACC-5DF17D27F1CAQ41023156-4EBDC9FA-BAB4-43AB-86CD-3D9FAD25D194Q41482439-A5A78B79-A9F8-4335-A8DC-102A5E12E71CQ41535392-A62DF740-9ABC-477B-BA28-496F8A989F01Q41545916-07C6CE39-56C6-472B-BF46-9617A220BD28Q41611462-C033A588-3E66-45EE-82C6-05D02BF66786Q42429532-336A84D3-B48B-4B69-A5EB-A08B208539E4Q46946207-0DD200F6-036F-42C7-B492-B4E4283E2210Q50229991-F94DF26D-E7F1-44EE-87E1-136F9FED0446Q53071816-CC5A71FB-8DC7-461C-8948-54B357237C14Q58799284-CEB88AA2-2F56-4AAD-8960-C628BF4774D5
P2860
Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Reversible skeletal disease an ...... tients receiving voriconazole.
@en
Reversible skeletal disease an ...... tients receiving voriconazole.
@nl
type
label
Reversible skeletal disease an ...... tients receiving voriconazole.
@en
Reversible skeletal disease an ...... tients receiving voriconazole.
@nl
prefLabel
Reversible skeletal disease an ...... tients receiving voriconazole.
@en
Reversible skeletal disease an ...... tients receiving voriconazole.
@nl
P2093
P1433
P1476
Reversible skeletal disease an ...... tients receiving voriconazole.
@en
P2093
Bernhard Gerber
David Fasler
Gayathri Nair
Georg Stussi
Roman Guggenberger
Urs Schanz
P304
P356
10.1182/BLOOD-2012-01-403030
P407
P577
2012-08-02T00:00:00Z